TPIV TapImmune to Present at the 3rd Annual Growth Capital Expo in Las Vegas on May 4, 2016
TapImmune,Inc. (TPIV), a clinical-stage immune-oncology company specializing in the development of innovative peptide and gene-based immunotherapeutics and vaccines for the treatment of cancer & metastatic disease, today announced it will be presenting at the 3rd Annual Growth Capital Expo to be held on May 3rd - 5th, 2016 at Caesars Palace in Las Vegas, Nevada.
The Company presentation will be given at 8.00 am on Wednesday, May 4th by Dr. John N. Bonfiglio a TapImmune Board member and Strategic Advisor. Entry into Phase II clinical programs in breast and ovarian cancer will be discussed.
TapImmune management will be available for one-on-one investor meetings. The company's presentation will be webcast through the following link: http://wsw.com/webcast/gce3/.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.